Gross Margin

Earable Neuroscience partners with Tonino Lamborghini for a $1,999 brainband and joins the NSF's network, betting big on the new market of luxury cognitive tech.

A routine prenatal screen can now detect a virus that causes birth defects, offering a path to prevention and sparking calls to change medical guidelines.

As COO/CFO Ashim Gupta prepares for a key investor conference, UiPath aims to prove its 'agentic automation' strategy can deliver sustained growth.

LifeVantage heads to the ICR Conference to woo investors. Can its cellular health science overcome market headwinds and a volatile direct selling landscape?

Agribusiness leader Taylor Fresh Foods acquires a 16.3% stake in Monterey County's only local bank, signaling a powerful reinvestment in community banking.

Amid rising geopolitical risks, Taiwan's J-Star is exiting China to build an automated factory in the US, a bold move for the micro-cap company.

Array Technologies promotes two key executives, signaling an aggressive strategy to boost global revenue and product innovation in the booming solar tracker market.

A new facility in East Moline is turning landfill gas into clean fuel, helping Illinois meet its ambitious climate goals and redefining waste as a resource.

Private equity firm Windjammer Capital acquires MFG Chemical, signaling a major investment in the high-growth water treatment and industrial coatings markets.

With its first drug for a rare disease now on the market, Stealth BioTherapeutics bets its future on a deep pipeline targeting mitochondrial dysfunction.

From e-commerce to tech licensor, Linkage Global unveils smart headphones with AI translation and cultural heritage designs at CES 2026.

While US sales numbers declined in 2025, Mazda posted record CPO figures, earned top safety honors, and saw major growth in Canada and Mexico.

Limbach Holdings appoints M&A and operations expert Terry Dugan to its board, a strategic move aimed at accelerating growth in mission-critical markets.

Lucid crushed its 2025 production goals with a huge Q4 surge, but a widening gap between cars built and sold raises serious questions about demand.

With blockbuster sales from VYJUVEK, Krystal Biotech heads to J.P. Morgan with investors eager for news on its global growth and ambitious pipeline.

With record Q3 earnings and strong analyst ratings, Red Violet is set to present its identity intelligence growth strategy at the prestigious Needham conference.

EchoStar's soaring stock price has triggered a conversion option for its 2030 notes, creating a pivotal choice between debt, cash, and equity.

Scorpio Tankers locks in a five-year, $105M charter deal for two tankers, a strategic move to ensure revenue stability amid a volatile shipping market.

Ingevity divests its North Charleston CTO assets to Mainstream Pine Products, sharpening its focus on high-margin activated carbon and advanced polymers.

In a major win, Rockwell Medical extends its DaVita supply deal through 2026 with a price hike, underscoring the value of its reliable supply chain.